Cover Image
市場調查報告書

qPCR及dPCR器具的全球市場

qPCR and dPCR Instrumentation

出版商 Global Industry Analysts, Inc. 商品編碼 290727
出版日期 內容資訊 英文 288 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
qPCR及dPCR器具的全球市場 qPCR and dPCR Instrumentation
出版日期: 2015年02月01日 內容資訊: 英文 288 Pages
簡介

本報告以全球qPCR(定量的聚合酵素鏈鎖反應)及dPCR(數位聚合酵素鏈鎖反應)器具市場為焦點,從一次及二次調查中所獲得的市場資料和分析資訊,依各最終用途(教育/研究,檢驗研究所,藥品公司)及地區別(美國,加拿大,日本,歐洲,亞太地區,中東·非洲,南美)提供以2009-2020年這段期間為對象的實際成果及預測分析,再彙整41家主要·精銳參與企業的最新簡介。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告的水準
    • 定量技術及分析法
  • 產品定義和調查的範圍
    • qPCR(定量的聚合酵素鏈鎖反應)
    • dPCR(數位聚合酵素鏈鎖反應)

第2章 摘要整理

  • 產業概要
    • 聚合酵素鏈鎖反應(PCR):遺傳基因放大及定量化上的重要部分
    • 在研究所中保持qPCR(定量的聚合酵素鏈鎖反應)和dPCR的恰當平衡
    • qPCR:適合遺傳基因表現及檢驗的工具
    • 隨著qPCR技術的成熟也面臨了飽和化
    • dPCR具有將核酸定量化引導到下一個階段的可能性
    • 儘管dPCR來襲,qPCR仍有存在意義
    • dPCR:病毒研究中的貴重工具
    • 偵測病毒的高靈敏度
    • 病毒參考標準的作成與檢驗
    • 高精度的定量化
    • 數位PCR的銷售額預計將在近期飛躍性成長
    • 新dPCR系統預測將可在全PCR市場上獲得更大比例
    • 高引進成本依然是妨礙dPCR普及的原因
  • 成長推動因素,市場趨勢,課題
    • 癌症發病率和罹患率的上升:促進qPCR和dPCR需求的可怕現實
    • 醫療支出的改善促進了使用qPCR及dPCR試驗的需求
    • 人類基因體計劃及分子診斷的進步促進遺傳基因放大技術的需求
    • 預測性遺傳基因診斷及檢驗的未來看好
    • 應用科學上的用途範圍擴大促進了qPCR器具及消耗品的需求
    • qPCR和NGS促進單細胞基因學市場
    • 探針技術的進步提高了qPCR的靈敏度
    • qPCR市場提高了自動·機器人設備的親和性
    • 影響實驗室用機器人選擇的因素 其他
  • 競爭
    • 各企業主要qPCR產品
    • Thermo Fisher Life Sciences Solutions:主要的企業
    • 專利到期Thermo Fisher Life Sciences對權利金收入的影響
    • PCR器具及試劑的成本下降
    • dPCR市場上競爭激烈
    • 激烈競爭帶來大量的M&A
    • 製造商開始從事線上銷售
    • PCR產業上求持續整合的複數因素
    • 加速產品商品化
    • 提供整合及多重技術解決方案
    • 製造商以擴大流通範圍為目標
  • 最終用途市場分析
    • PCR的應用領域
    • 醫療和診斷
    • PCR在傳染病診斷中扮演重要角色
    • 抗微生物抗性的檢測
    • 司法鑑定及親子鑑定檢驗
    • 食品安全性
    • 食品病原菌的檢測和定量評估
    • 檢測有效性的非病原性微生物
    • 微生物對環境反應的相關研究
    • 微生物風險評估
    • GMO的鑑定上,PCR技術
    • 研究和學術機構
    • SWBR染料和Taqman技術在研究論文出版中受歡迎
  • 產品概要
    • 聚合酵素鏈鎖反應(PCR)的簡介
    • PCR所需的試劑和因素
    • 反應階段
    • 變性
    • Annealing
    • 擴張
    • 即時PCR或定量的PCR(qPCR) 其他
  • 生命科學研究的全球投資概要
  • 產品開發/發表
  • 最近的產業趨勢
  • 主要企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 其他
  • 中東·非洲
  • 南美

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7856

This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Thousands by the following Product Segments: qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction). Also, the report analyzes the following End-Uses: Educational/Research, Testing Laboratories, Pharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 41 companies including many key and niche players such as -

Agilent Technologies, Inc.
Becton, Dickinson and Company
BioFire Diagnostics, Inc.
Bio-Rad Laboratories, Inc.
Cepheid

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of the Study
    • qPCR
    • dPCR

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
  • Striking the Right Balance between qPCR and dPCR in Research Laboratories
  • qPCR- A Suitable Tool for Gene Expression and Validation
    • Select qPCR Systems Available in Marketplace
      • Thermo Fisher Life Sciences Prism 7000 Series
      • Thermo Fisher Life Sciences ViiA 7
      • Thermo Fisher Life Sciences QuantStudio
      • Cepheid SmartCycler Platform
      • Roche LightCycler Platform
      • Roche FLOW
  • As qPCR Technology Matures, Saturation is Imminent
    • Table 1: Global qPCR Instrumentation Market by Category (2014): Percentage Share Breakdown of Annual Revenues for Reagents and Instruments (includes corresponding Graph/Chart)
  • Digital PCR Holds Potential to Take Quantification of Nucleic Acids to the Next Level
  • Despite Onslaught of Digital PCR, qPCR Maintains Relevance
  • dPCR - A Valuable Tool in Virology Research
  • High Sensitivity in Viral Detection
    • Table 2: World PCR Market for Clinical Diagnosis of Infectious Diseases by Type of Disease (2014): Percentage Market Share Breakdown for Hepatitis B & Hepatitis C Test, Tuberculosis Diagnosis, HIV Diagnosis, and Others (includes corresponding Graph/Chart)
    • Table 3: Worldwide PCR Market for Clinical Diagnosis of Non-Infectious Diseases by Type of Disease (2014): Percentage Market Share Breakdown for Hepatitis B & Hepatitis C Test, Tuberculosis Diagnosis, HIV Diagnosis, and Others (includes corresponding Graph/Chart)
  • Creation and Validation of Viral Reference Standards
  • High-Precision Quantification
  • Digital PCR Sales to Skyrocket in the Near Term
  • New dPCR Systems to Capture a Bigger Slice of the Overall PCR Market
    • Table 4: Leading dPCR Systems at a Glance
  • QuantStudio 3D Digital PCR System
  • QuantStudio 12K
  • BioMark HD system
  • QX100 droplet digital PCR System
  • RainDrop Systems
  • High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
    • Table 5: Price Range of Select PCR Equipment of Thermo Fisher Life Sciences Solutions

2. GROWTH DRIVERS, MARKET TRENDS & ISSUES

  • Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
    • Table 6: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
    • Table 7: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 8: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 9: Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 10: Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 11: Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 12: Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
    • Table 13: Per-Capita Healthcare Expenditure in Select Regions: 2014E (includes corresponding Graph/Chart)
  • Progress in Human Genome Project and Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
  • Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
  • Expanding Scope of Applications in Applied Sciences Drive Demand for qPCR Instruments and Supplies
  • qPCR and NGS to Drive Single-Cell Genomics Market
  • Advancements in Probe Technology Enhance qPCR Sensitivity
  • qPCR Market to Witness increasing Affinity for Automated and Robotic Equipment
  • Factors influencing Selection of Lab Robots
  • Lab on Chip/Microfluidic Real-time-PCR- A Game Changer in the Offing
  • Two Types of Microfluidic Designs
  • Advantages of Lab on Chip PCR
  • Roadblocks in the Path to Development
  • New Developments in Lab-on-chip PCR
  • Droplet digital PCR Finds Increasing Application in Life Sciences Research
  • ddPCR gains Traction in Cancer Diagnosis
  • Monitoring Disease Progression in HIV Studies
  • Analysis of Genetically Modified Organisms in Edible Products
  • RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
  • Researchers Continue to Campaign for Adoption and Strict Compliance with MIQE and SPIDIA Guidelines
  • Alternate Technologies Pose Threat to Growth of PCR Market
  • New Isothermal PCR Technology - A Potential Game Changer Promising Faster PCR

3. COMPETITION

    • Table 14: Global qPCR Instruments Market by Leading Player (2014): Percentage Market Share Breakdown of Value Sales for Life Sciences Research for Thermo Fisher Life Sciences, Bio-Rad, Roche, Agilent, Qiagen, and Others (includes corresponding Graph/Chart)
  • Select qPCR Products by Company
  • Thermo Fisher Life Sciences Solutions - The Leading Player
    • Table 15: PCR Systems Product Portfolio of Thermo Fisher Life Sciences Solutions
  • Patent Expiries Impact Royalty Revenues Inflow of Thermo Fisher Life Sciences
    • Table 16: Life Technologies' Royalty Roll-Off by Year: 2009-2013 (includes corresponding Graph/Chart)
  • Cost of PCR instruments and Reagents to Decline
  • Competition Heats Up in dPCR Market
  • Intense Competition Triggers a Spate of M&A
  • Manufacturers Step-Up Online Exposure
  • Multiple Factors to Sustain Consolidation Trend in PCR Industry
  • Accelerated Commercialization of Products
  • Offering Integrated and Multi-technology Solutions
  • Manufacturers Target Expansion of Distribution Reach and Global Footprint

4. END-USE MARKET ANALYSIS

  • Application Areas of PCR
  • Medical and Diagnostics
  • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
  • Detection of Antimicrobial Resistance
    • PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
  • Forensic and Paternity Testing
  • Food Safety
  • Detection and Quantification of Food Pathogens
  • Detection of Beneficial and Non-Pathogenic Microbes
  • Study of Microbial Responses to Environment
  • Microbial Risk Assessment
    • qPCR Application in Food Microbiology: Study of Select Micro-Organisms by Target Gene and Food Substrate
  • PCR Technique in Identification of GMOs
  • Research & Academics
  • SYBR Dye and TaqMan Techniques Popular in Research Publications

5. PRODUCT OVERVIEW

  • Introduction to Polymerase Chain Reaction (PCR)
  • Reagents and Components Required for PCR
  • Reaction Steps
  • Denaturation
  • Annealing
  • Extension
  • Real-Time PCR or Quantitative PCR (qPCR)
  • qPCR Instrumentation
    • Evolution
    • Working of qPCR Instruments
      • Thermal Control
      • Fluorimetry
      • DNA Detection Methods
      • Fluorescence Measurement
      • Asymmetrical dsDNA dyes
      • Quantification
  • High-Throughput qPCR
  • Comparison of Working of Conventional PCR versus qPCR
  • Drawbacks in Core PCR
  • Advantages of qPCR
  • Disadvantages of qPCR
  • End-Use Applications of qPCR
  • Factors Influencing Purchase Decisions of qPCR Systems
  • qPCR Consumables, Accessories and Software
  • DIGITAL PCR
  • Development of dPCR
  • Working Principle
  • Droplet dPCR
  • Applications of dPCR
  • Advantages of dPCR

6. INSIGHT INTO GLOBAL SPENDING ON LIFE SCIENCES RESEARCH

  • Global Life Sciences Research and Development Landscape
    • Table 17: Select Countries with R&D Spending as a % of GDP: 2014 (includes corresponding Graph/Chart)
  • Sequestration Bites Deep into US Research Funds
    • Table 18: NIH Annual Appropriations in US$ Billions, and RPG Funding (2008-2014) (includes corresponding Graph/Chart)
    • Table 19: NCI Research Spending in US$ Millions on Major Types of Cancers Listed in Decreasing Order of Prevalence (2010, 2011, 2012 & 2013) (includes corresponding Graph/Chart)
  • New MoPath Codes for Reimbursement for Medical Diagnostics Tests
  • Government Takes Major Steps to Revive Japan Life Sciences Sector
    • Table 20: Human Frontier Science Program Budget for 2014 by Country: Contribution in US$ Million for Japan, United States, European Union, and Others (includes corresponding Graph/Chart)
    • Table 21: Japanese Government Stimulus Package for Life Sciences Sector: 2013 (includes corresponding Graph/Chart)
  • Fiscal Prudence to Undermines Research Programs
    • Table 22: European Research Council (ERC) Funding for Life Sciences by Country (2008-2013): Breakdown of Number of Starting Grants Allocated for United Kingdom, Germany, France, Israel, Switzerland, Netherlands, Sweden, Spain, Belgium, Austria, and Others (includes corresponding Graph/Chart)
    • Table 23: European Research Council (ERC) Funding for Life Sciences by Country (2008-2013): Breakdown of Number of Advance Grants Allocated for United Kingdom, Germany, France, Switzerland, Netherlands, Italy, Israel, Spain, Sweden, Belgium, and Others (includes corresponding Graph/Chart)
  • Asia Pacific - The New Global Hub for Life Sciences Research

7. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Agilent Technologies Launches AriaMx System
  • Life Technologies Launches QuantStudio 3D Digital PCR System
  • LGC Introduces Updated 1536-Well PCR Plate for Genomics Applications
  • Exiqon Unveils Toxicology Focus microRNA PCR Panel
  • Exiqon Introduces LNA™ LongRNA GapmeR Products
  • Life Technologies and Quidel Secure US FDA Approval for Marketing qPCR Instruments
  • Life Technologies Obtains US FDA Approval for 3500 Dx Genetic Analyzers and SeCore® HLA Typing Kit
  • Bio-Rad Laboratories Unveils QX200 ddPCR System
  • Exiqon Introduces Customized qPCR Arrays
  • Life Technologies Provides QuantStudio 3D Digital PCR System to Five Research Labs
  • Bio-Rad Unveils iTaq Universal Supermixes
  • Nextreme Thermal Solutions Introduces New-Generation Reference Design for Compact PCR Thermal Cycler
  • Sigma Life Science Introduces KiCqStart Primers
  • Bio-Rad Rolls Out CFX96 Touch Deep Well PCR Detection System
  • Roche Introduces Light Cycler 96 System
  • Fluidigm Rolls Out New Integrated Fluidic Circuits
  • Promega Unveils GoTaq Master Mixes Range
  • Illumina Unveils Real-Time PCR Reagent Portfolio
  • Integromics® Introduces OmicsOffice® Platform
  • Ingenuity Systems and Life Technologies Unveil Ingenuity iReport for Real-Time PCR
  • Life Technologies Introduces QuantStudio™ Dx Real-Time PCR Instrument
  • RainDance Technologies Introduces RainDrop™ Digital PCR Platform
  • Life Technologies Unveils QuantStudio 3D Digital PCR System Chip-Based Instrument
  • Integromics® Unveils RealTime StatMiner® 4.3 on TIBCO® Spotfire®
  • Bio-Rad Laboratories Unveils CFX Qualification Plate
  • Exiqon Unveils miRCURY™ RNA Isolation Kit-Biofluids
  • Bio-Rad Laboratories Launches One-Step RT-ddPCR Kit
  • Accelero® Bioanalytics Announces Addition of RT-qPCR System of Applied Biosystems

8. RECENT INDUSTRY ACTIVITY

  • Thermo Fisher Scientific Completes Take Over of Life Technologies
  • Quotient Bioresearch Divests Bioanalytical Sciences Business to LGC
  • Thermo Fisher Scientific Inks Definitive Agreement to Take Over Life Technologies
  • QIAGEN and WaferGen Bio-systems Ink Co-Marketing Agreement
  • Biodesign Institute® Enters into Partnership with Life Technologies
  • WaferGen Bio-systems Enters into Partnership with Salk Institute to Establish nano-qPCR Core Laboratory
  • TATAA Biocenter Extends Product Line
  • Integrated DNA Technologies to Showcase Novel Multiplex qPCR Assays
  • Illumina and VWR International Sign Agreement
  • Integrated DNA Technologies Collaborates with RainDance Technologies
  • Life Technologies Takes Over Compendia Bioscience
  • Luminex Takes Over GenturaDx
  • Life Technologies Takes Over Pinpoint Genomics
  • Idaho Technology Announces Corporate Rebranding to BioFire Diagnostics
  • Exosome Diagnostics and Life Technologies Ink Agreement
  • Abbott Inks Partnership Agreement with Astellas Pharma Global Development for Executing Clinical Trial on TransVax™ Vaccine
  • Accelero Bioanalytics and Synlab Clinical Trial Enter into Collaboration
  • Immunexpress Group, Biocartis and Debiopharm Ink Agreement to Develop and Commercialze SeptiCyte® Triage Assay
  • Accelero Bioanalytics Collaborates with LPT Laboratory

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Agilent Technologies, Inc. (US)
  • Becton, Dickinson and Company (US)
  • BioFire Diagnostics, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Cepheid (US)
  • Eppendorf AG (Germany)
  • Exiqon A/S (Denmark)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fluidigm Corporation (US)
  • Illumina, Inc. (US)
  • Promega Corporation (US)
  • RainDance Technologies, Inc. (US)
  • QIAGEN N.V. (Netherlands)
  • Takara Bio, Inc. (Japan)
  • Thermo Fisher Scientific Inc. (US)

10. GLOBAL MARKET PERSPECTIVE

    • Table 24: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 26: World 12-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for qPCR and dPCR Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for qPCR and dPCR Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 29: World 12-Year Perspective for qPCR and dPCR Reagents by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for qPCR and dPCR Instruments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 32: World 12-Year Perspective for qPCR and dPCR Instruments by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 33: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Product Segment - qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Product Segment - qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 35: World 12-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Product Segment - Percentage Breakdown of Revenues for qPCR and dPCR Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 36: World Recent Past, Current & Future Analysis for qPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 37: World Historic Review for qPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 38: World 12-Year Perspective for qPCR Instrumentation and Reagents by Product Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 39: World Recent Past, Current & Future Analysis for dPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 40: World Historic Review for dPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 41: World 12-Year Perspective for dPCR Instrumentation and Reagents by Product Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 42: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by End-Use Segment - Educational/ Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: World Historic Review for qPCR and dPCR Instrumentation and Reagents by End-Use Segment - Educational/Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 44: World 12-Year Perspective for qPCR and dPCR Instrumentation by End-Use Segment - Percentage Breakdown of Revenues for Educational/ Research, Testing Laboratories and Pharma Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • qPCR Vs. dPCR Instrumentation is the US
    • Cancer Stats
    • Table 45: New Cancer Cases in the US by Gender and Affected Site: 2014
    • Table 46: New Cancer Cases in Males in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 47: New Cancer Cases in Females in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 48: New Cancer Cases in US by State: 2014
    • Table 49: The US Cancer Incidence for All Body Sites by Gender & Age Group (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; and 65 years and Above (includes corresponding Graph/Chart)
    • Cancer Mortality Statistics
    • Table 50: Cancer Related Deaths in the US by Gender and Body Site: 2014
    • Table 51: Cancer Related Deaths in Males in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 52: Cancer Related Deaths in Females in US by Leading Site: 2014 (includes corresponding Graph/Chart)
    • Table 53: Number of Deaths Related to Major Types of Cancer in US by State: 2014
    • Competition
    • Product Introductions
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 54: The US Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 55: The US Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 56: The US 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2013 & 2018 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Cancer Statistics in Canada
    • Table 57: New Cancer Cases in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
    • Table 58: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart)
    • Table 59: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
    • Table 60: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
    • Table 61: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart)
    • Table 62: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
    • Funglyn Biotech, Inc. - A Key Player
  • B. Market Analytics
    • Table 63: Canadian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Canadian Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 65: Canadian 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Table 66: Cancer Related Deaths by Age Group: 2013 (includes corresponding Graph/Chart)
    • Takara Bio, Inc. - A Key Player
  • B. Market Analytics
    • Table 67: Japanese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 68: Japanese Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 69: Japanese 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • PCR Reagents in Europe: An Overview
    • Cancer Stats
    • Table 70: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 71: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 72: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 73: European Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 74: European 12-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 75: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 76: European Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 77: European 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 78: French Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 79: French Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 80: French 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Product Introduction
    • Strategic Corporate Developments
    • Eppendorf AG - A Key German Player
  • B. Market Analytics
    • Table 81: German Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 82: German Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 83: German 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 84: Italian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 85: Italian Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 86: Italian 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Product Introductions
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 87: The UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 88: The UK Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 89: The UK 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Current And Future Analysis
    • Product Introductions
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 90: Rest of European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 91: Rest of European Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 92: Rest of European 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 93: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 94: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 95: Asia-Pacific 12-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 96: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2018 (includes corresponding Graph/Chart)
    • Table 97: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 98: Asia-Pacific 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 99: Chinese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 100: Chinese Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 101: Chinese 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current And Future Analysis
    • Strategic Corporate Development
    • Professional Biotech Pvt. Ltd. - A Key Real Time PCR Manufacturer In India
  • B. Market Analytics
    • Table 102: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 103: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 104: Rest of Asia-Pacific US 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 105: The Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 106: The Middle East Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 107: The Middle East 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 108: Latin American Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 109: Latin American Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
    • Table 110: Latin American 12-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top